These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26179199)

  • 1. The growing problem of benign connective tissue tumours.
    Thomas DM
    Lancet Oncol; 2015 Aug; 16(8):879-80. PubMed ID: 26179199
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
    Cassier PA; Italiano A; Gomez-Roca CA; Le Tourneau C; Toulmonde M; Cannarile MA; Ries C; Brillouet A; Müller C; Jegg AM; Bröske AM; Dembowski M; Bray-French K; Freilinger C; Meneses-Lorente G; Baehner M; Harding R; Ratnayake J; Abiraj K; Gass N; Noh K; Christen RD; Ukarma L; Bompas E; Delord JP; Blay JY; Rüttinger D
    Lancet Oncol; 2015 Aug; 16(8):949-56. PubMed ID: 26179200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.
    Brahmi M; Vinceneux A; Cassier PA
    Curr Treat Options Oncol; 2016 Feb; 17(2):10. PubMed ID: 26820289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
    Ravi V; Wang WL; Lewis VO
    Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
    Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
    Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Approaches to Cancer Drug Development.
    Chabner B; Richon V
    N Engl J Med; 2015 Jul; 373(5):402-3. PubMed ID: 26222556
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
    Blay JY; El Sayadi H; Thiesse P; Garret J; Ray-Coquard I
    Ann Oncol; 2008 Apr; 19(4):821-2. PubMed ID: 18296418
    [No Abstract]   [Full Text] [Related]  

  • 8. Pigmented villonodular synovitis therapy with MSCF-1 inhibitors.
    Temple HT
    Curr Opin Oncol; 2012 Jul; 24(4):404-8. PubMed ID: 22572726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.
    Fiocco U; Sfriso P; Lunardi F; Pagnin E; Oliviero F; Scagliori E; Cozzi L; Vezzù M; Molena B; Scanu A; Panziera C; Nardacchione R; Rubaltelli L; Dayer JM; Calabrese F; Punzi L
    Autoimmun Rev; 2010 Sep; 9(11):780-4. PubMed ID: 20620241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
    Tap WD; Wainberg ZA; Anthony SP; Ibrahim PN; Zhang C; Healey JH; Chmielowski B; Staddon AP; Cohn AL; Shapiro GI; Keedy VL; Singh AS; Puzanov I; Kwak EL; Wagner AJ; Von Hoff DD; Weiss GJ; Ramanathan RK; Zhang J; Habets G; Zhang Y; Burton EA; Visor G; Sanftner L; Severson P; Nguyen H; Kim MJ; Marimuthu A; Tsang G; Shellooe R; Gee C; West BL; Hirth P; Nolop K; van de Rijn M; Hsu HH; Peterfy C; Lin PS; Tong-Starksen S; Bollag G
    N Engl J Med; 2015 Jul; 373(5):428-37. PubMed ID: 26222558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-1R Inhibitor Development: Current Clinical Status.
    Peyraud F; Cousin S; Italiano A
    Curr Oncol Rep; 2017 Sep; 19(11):70. PubMed ID: 28875266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor.
    Sikaria S; Heim-Hall J; Diaz EH; Williams R; Sankhala K; Laabs B; Mita M
    Target Oncol; 2014 Mar; 9(1):73-9. PubMed ID: 23430345
    [No Abstract]   [Full Text] [Related]  

  • 13. Tenosynovial giant cell tumor and pigmented villonodular synovitis.
    Folpe AL
    Skeletal Radiol; 2007 Sep; 36(9):899-900; author reply 901. PubMed ID: 17579851
    [No Abstract]   [Full Text] [Related]  

  • 14. Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis.
    Molena B; Sfriso P; Oliviero F; Pagnin E; Teramo A; Lunardi F; Stramare R; Scanu A; Nardacchione R; Rubaltelli L; Calabrese F; Punzi L; Fiocco U
    Clin Exp Rheumatol; 2011; 29(3):547-50. PubMed ID: 21640049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb perfusion as a treatment option for rare types of tumours.
    Belgrano V; Ben-Shabat I; Bergh P; Olofsson Bagge R
    Int J Hyperthermia; 2016 Sep; 32(6):595-9. PubMed ID: 27269515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenosynovial giant cell tumor and pigmented villonodular synovitis: a proposal for unification of these clinically distinct but histologically and genetically identical lesions.
    Rubin BP
    Skeletal Radiol; 2007 Apr; 36(4):267-8. PubMed ID: 17225151
    [No Abstract]   [Full Text] [Related]  

  • 17. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenosynovial giant cell tumor: case report and review.
    Lucas DR
    Arch Pathol Lab Med; 2012 Aug; 136(8):901-6. PubMed ID: 22849738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature.
    Maheshwari AV; Muro-Cacho CA; Pitcher JD
    Knee; 2007 Oct; 14(5):402-7. PubMed ID: 17669658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Giant cell tumors. A review the literature].
    Vindenes H
    Tidsskr Nor Laegeforen; 1985 Apr; 105(12):806-9. PubMed ID: 3892765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.